Dosing tiers: Administer two to three hours before intended sleep time, not immediately at bedtime
Relapse rates for alcohol use disorders are estimated to be between 40-60%, which is comparable to other chronic diseases like hypertension and diabetes
Dose: 1mg to 2mg daily Frequency: Once daily, typically morning Administration: Subcutaneous injection Duration: 30 days on, 14 days off The cycling pattern prevents potential receptor desensitization and gives the body periodic breaks from exogenous copper peptide input
Sourcing considerations 5-amino-1mq is available from various peptide and research chemical suppliers
Mike Israetel is a doctor in sports physiology, a bodybuilder, and a popular YouTube personality
Yet the consequences are unknown Bioavailability: there are four specific metabolic steps necessary to convert cyanocobalamin into one of the coenzyme forms, which is a clear metabolic disadvantage (3) Utilisation problems: certain hereditary diseases, as well as metabolic disorders, prevent the conversion of cyanocoalamin into the active B12 forms (4) Steals methyl groups: cyanocobalamin requires a methyl group to convert into methylcobalamin, which it takes from the important amino acid S-adenosylmethionine (SAM)